You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abemaciclib i

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

Recruiting
  • Neurofibromatosis 1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Kaposi Sarcoma Trial run by the NCI (Abemaciclib)

Recruiting
  • Kaposi Sarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Brain Metastases, HR+ Metastatic Breast Cancer Trial in Tampa (Stereotactic Radiosurgery (SRS), Abemaciclib, Endocrine therapy)

Recruiting
  • Brain Metastases
  • HR+ Metastatic Breast Cancer
  • Stereotactic Radiosurgery (SRS)
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Nov 1, 2022

Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +1 more
Dec 14, 2022

Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

Recruiting
  • Myelofibrosis Due to and Following Polycythemia Vera
  • Basking Ridge, New Jersey
  • +6 more
Jan 26, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
    University of California, San Francisco
Sep 8, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Birmingham, Alabama
  • +12 more
Nov 9, 2022

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Metastatic Esophageal Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Dallas (Abemaciclib,

Not yet recruiting
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Dallas, Texas
    Baylor University Medical Center, Charles A Sammons Cancer Cente
Jun 4, 2021

Sarcoma, Ewing, Tumor Metastasis Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Neoplasm Metastasis
  • Phoenix, Arizona
  • +29 more
Aug 17, 2022

Early Breast Cancer Trial in Spain (Doxorubicin, Cyclophosphamide, Taxane)

Active, not recruiting
  • Early Breast Cancer
  • Santiago De Compostela, A Coruña, Spain
  • +27 more
Jul 11, 2022

Metastatic or Local Advanced Breast Cancer of Patients Trial in Beijing, Changchun (HRS-8080 tablets?SHR 6390

Enrolling by invitation
  • Metastatic or Local Advanced Breast Cancer of Patients
  • HRS-8080 tablets、SHR 6390 tablets、Abemaciclib、Everolimus
  • Beijing, Beijing, China
  • +1 more
Apr 2, 2022

Advanced Breast Cancer Trial in Italy (Abemaciclib, Aromatase Inhibitors)

Recruiting
  • Advanced Breast Cancer
  • Ancona, Italy
  • +43 more
Jan 31, 2022

Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, procedure, other)

Terminated
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 9, 2020

Sarcoma, Dedifferentiated Liposarcoma Trial in New York (Abemaciclib)

Active, not recruiting
  • Sarcoma
  • Dedifferentiated Liposarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 17, 2022

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

Suspended
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • Boston, Massachusetts
    Dana-Farber - Harvard Cancer Center LAO
Sep 17, 2022

Prostate Cancer Trial in Worldwide (Abemaciclib, Abiraterone Acetate, Prednisone)

Recruiting
  • Prostate Cancer
  • Phoenix, Arizona
  • +116 more
Aug 17, 2022

Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)

Withdrawn
  • Solid Tumor
  • Advanced Breast Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Dec 21, 2022

Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)

Not yet recruiting
  • Prostatic Neoplasms
  • Mineola, New York
  • +14 more
Aug 23, 2023

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Boston

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 3, 2022

Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in United States

Suspended
  • Recurrent Ovarian High Grade Serous Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Phoenix, Arizona
  • +8 more
Jul 26, 2022

Breast Cancer Trial (Abemaciclib, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Nov 14, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Glioma Trial run by the National Cancer Institute (NCI) (pre-operative abemaciclib, Device for Cerebral Fluid Dialysate

Recruiting
  • Glioma
  • pre-operative abemaciclib
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023